Want to track VALN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Can Valneva (VALN) Climb 149.04% to Reach the Level Wall Street Analysts Expect?
The consensus price target hints at a 149% upside potential for Valneva (VALN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks | 2 years ago
Valneva (VALN) Gets EC's Approval on Chikungunya Vaccine
Valneva (VALN) gets European Commission???s marketing authorization in Europe for Valneva?
Zacks | 2 years ago
Valneva's (VALN) CHIKV Vaccine Gets Health Canada's Approval
Valneva's (VALN) IXCHIQ, the world's only licensed chikungunya vaccine, is a critical tool in combating this public health threat.
Zacks | 2 years ago
2026 © Marketlog. All Rights Reserved.
